EUVIMEDEUVIMED entdecken
Crossref

Induction therapy in advanced sinonasal cancers: outcomes, selection, and preservation

Shorook Naara, Renata Ferrarotto, Luana Sousa, Neal Akhave, Brandon Gunn, Jack Phan, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna

Academia Oncology · 21.07.2026 · 3 (3)

DOI: 10.20935/acadonco8421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Oncology, online erschienen am 21.07.2026. Verfasst von Shorook Naara und 9 weiteren Autor:innen. Die Arbeit nennt 69 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sinonasal malignancies are rare, biologically heterogeneous tumors that frequently present at an advanced stage with involvement of critical structures such as the orbit and skull base. Historically, management relied on radical surgical resection followed by adjuvant radiotherapy, often resulting in substantial morbidity and modest long-term survival. Over the past two decades, induction systemic therapies have emerged as integral components of multimodality treatment for selected patients with locally advanced disease. Induction strategies, initially centered on cytotoxic chemotherapy and more recently expanded to include immunotherapy, have enabled early cytoreduction, treatment of occult micrometastatic disease, and assessment of tumor biology. Across major sinonasal tumor subtypes, response to induction therapy has consistently demonstrated prognostic value and has informed response-adapted treatment selection, allowing for de-escalation of surgical extent and improved preservation of the orbit, skull base, and adjacent neurovascular structures without compromising oncologic outcomes. This review provides a contemporary synthesis of evidence supporting induction-based approaches in sinonasal squamous cell carcinoma, sinonasal undifferentiated carcinoma, olfactory neuroblastoma, NUT carcinoma, SMARCB1-deficient sinonasal carcinoma, and sinonasal mucosal melanoma, with emphasis on histology-specific treatment responsiveness, the evolving role of induction immunotherapy, and the impact of induction therapy on surgical decision-making.

Zitieren

APA

Naara, S., Ferrarotto, R., Sousa, L., Akhave, N., Gunn, B., Phan, J., Su, S. Y., Raza, S. M., DeMonte, F., & Hanna, E. (2026). Induction therapy in advanced sinonasal cancers: outcomes, selection, and preservation. Academia Oncology, 3(3). https://doi.org/10.20935/acadonco8421

Vancouver

Naara S, Ferrarotto R, Sousa L, Akhave N, Gunn B, Phan J, et al. Induction therapy in advanced sinonasal cancers: outcomes, selection, and preservation. Academia Oncology. 2026;3(3). doi:10.20935/acadonco8421

BibTeX
@article{Naara2026,
  author = {Naara, Shorook and Ferrarotto, Renata and Sousa, Luana and Akhave, Neal and Gunn, Brandon and Phan, Jack and Su, Shirley Y. and Raza, Shaan M. and DeMonte, Franco and Hanna, Ehab},
  title = {Induction therapy in advanced sinonasal cancers: outcomes, selection, and preservation},
  journal = {Academia Oncology},
  year = {2026},
  volume = {3},
  number = {3},
  doi = {10.20935/acadonco8421}
}
Kostenlos starten →